Skip to Main Content

Launch Your Career

When you join Weil, you are not just getting a job – you are launching a career. You will work together with Weil colleagues, and partner with clients to hone your skills as a business lawyer. In doing so, you will be building capabilities that can take you in many different professional directions. You will also have access to robust training and professional development programs.

Our success stems from our role as strategic business partners and as innovative problem solvers for clients wherever they operate. Talented individuals who want a seat at the table and to tackle complex, challenging matters on behalf of world-class companies will find ample opportunities to shine.

With approximately 1,100 lawyers spread across offices on three continents, the Firm offers clients complex corporate megadeals expertise, leading trial capabilities across practices, and unmatched bankruptcy experience. Weil advised on more than 100 transactions with deal values above $1 billion in the last year alone, secured four multi-hundred million dollar trial victories in antitrust, product liability, and patent disputes in the past 12 months, and has represented clients in five of the six largest U.S. bankruptcies in history

In the News

With myriad rankings by publications such as The American Lawyer, Financial Times, and Chambers & Partners, Weil continues to burnish its reputation as one of the world’s most prestigious firms. In 2018, Weil won more than 80 awards in the United States alone, including more than 60 awards recognizing individual lawyers for their outstanding achievements.

Some highlights for 2018 include:

  • 14 lawyers received a total of 23 recognitions as “Rising Stars”
  • Four lawyers recognized as “Trailblazers” by National Law Journal
  • Four “Practice Group of the Year” awards by Law360  
  • Three lawyers recognized as MVPs by Law360

Delivering on Dynamic Deals


Weil’s market leading corporate practice continues to advise on many of the largest and most high-profile M&A deals in the market – you’ve likely read about some of them in publications like The Wall Street Journal and New York Times. Weil consistently ranks as a top M&A firm in the United States and globally by all of the major league tables. Indeed, over the last 5 years, Weil has handled more than 1,500 deals totaling more than $2.1 trillion in deal value. Further, in the last year alone, Weil advised on more than 100 $1B+ deals. Our clients include a veritable list of brand name public companies, including: Belmond; Campbell Soup Company; Dow Chemical; General Electric; The Home Depot; Intel; Kroger; L’Oréal; MGM Resorts; Procter & Gamble; Sanofi; Synchrony Financial; Scripps Networks; Verizon; Walgreens; Walmart and Willis Towers Watson, among others.

Examples of recent M&A representations include advising:

  • Brookfield Asset Management and Brookfield Property Partners (BPY) in BPY's $14.4 billion acquisition of the approximately 66% of common stock that it did not already own of GGP Inc. (f/k/a General Growth Properties);
  • Sanofi in its:
    • $11.6 billion acquisition of Bioverativ;
    • $4.8 billion acquisition of Ablynx;
  • athenaheath in its pending $5.7B sale to Veritas Capital and Evergreen Coast capital;
  • Campbell Soup Company in its $6.1 billion acquisition of Snyder’s-Lance;
  • Synchrony Financial in its $5.8 billion acquisition of U.S. consumer receivables from PayPal Holdings;
  • Westinghouse Electric Company in its $4.6 billion sale of substantially all of its global business to Brookfield Business Partners;
  • Atos in its $3.57 billion acquisition of Syntel;
  • Kinder Morgan and Kinder Morgan Canada Limited in their $3.5 billion sale of Trans Mountain Pipelines and the Trans Mountain Expansion Project to the Government of Canada;
  • SoftBank Vision Fund in its $2.25 billion minority investment in GM Cruise Holdings (Cruise), alongside a $1.1 billion investment in Cruise by GM;
  • The Kroger Company
    • in its $2.15 billion sale of its convenience store business unit, comprising, at the time, 762 stores operating in 18 states, to EG Group;
    • in its up-to $700 million acquisition of Relish Labs (d/b/a Home Chef);
  • Nexeo Solutions in its $2 billion sale to Univar;
  • Takata in its $1.6 billion sale in bankruptcy of substantially all of its assets to Key Safety Systems;
  • The Board of Directors of Iron Mountain Incorporated in its up to $1.375 billion acquisition of the U.S. operations of IO Data Centers;
  • Tidewater in its $1.25 billion combination with GulfMark Offshore;

Private Equity/Private Funds

Weil’s powerhouse private equity practice is recognized by the industry as being one of only a very small number of elite, market leaders in this field. The group is both diverse and versatile, as it advises on both private equity deal execution as well as fund formation. For the past two years, Weil has been named a “Private Equity Practice Group of the Year” by Law360. In addition, the group has received a Band 1 global-wide ranking for the eighth consecutive year from Chambers Global.

Our private equity clients include the majority of the largest and highest profile private equity funds, sovereign wealth funds and pension funds, as well as family offices and other equity financial investors. Our clients include: Advent International; Berkshire Partners; Blackstone; Canada Pension Plan Investment Board (CPPIB); Goldman Sachs Merchant Banking Division; Lindsay Goldberg; OMERS Private Equity; Providence Equity Partners and Providence Strategic Growth Partners; Public Sector Pension Investment Board and TPG and TPG Growth, among many others.

Weil’s Private Funds practice is one of the most comprehensive funds teams in the world with more than 60 dedicated private funds lawyers across the U.S. and Europe. We have a top-notch client base covering a broad range of the fund spectrum. Our clients include a diversified group of prominent managers extending from some of the largest, most well-established players to prominent and emerging participants in the middle market. Our clients include: American Securities/Ascribe Capital; Apollo; Berkshire Partners; Brookfield Asset Management; Crow Holdings; Genstar Capital; Lindsay Goldberg; Perella Weinberg Partners and Snow Phipps Group, among others. 


Additionally, Weil’s Finance practices also had a very busy 2018. The Banking & Finance and Capital Markets groups advised on the financings for several of 2018’s most high-profile and transformational deals that impacted a number of different industries, as well as on a number of public and private debt and equity offerings.

Our clients include the largest financial institutions, most sophisticated private equity firms and brand name public companies in the world. Our clients include: Advent International; AMC Entertainment, American Securities; Berkshire Partners; Brookfield Asset Management; Centerbridge Partners; Citi; Credit Suisse; Eli Lilly; EQT; Fidelity National Financial; General Electric; General Motors; Goldman Sachs; Johnson & Johnson; Lindsay Goldberg; Magellan Healthcare; Morgan Stanley; OMERS Private Equity; Ontario Teachers’ Pension Plan; Providence Equity Partners; The Estée Lauder Companies; Thomas H. Lee Partners and Willis Towers Watson among many others.

Weil 3 12 2018

Bankruptcy and Restructuring

Weil was involved in 13 of the largest bankruptcies filed in the U.S. in 2017, including acting as lead debtors’ counsel for Takata, one of 2017’s largest international restructurings. Similarly, 2018 was no different, as the Firm held prominent roles in the top two largest bankruptcies filed this year, representing the private equity sponsors of iHeartMedia and the representation of Sears Holdings Corporation respectively.  Weil continues to have key roles in many of the largest bankruptcies filed this year, including Claire’s Stores, Inc. and Fieldwood Energy. Other major bankruptcies the Firm is handling include Westinghouse, Walter Investment Management, Tops Supermarkets and Southeastern Grocers.

The Firm has a leading role in dozens of prominent bankruptcies in the most hard-hit sectors, including oil & gas, mining and retail, which is part of the reason why it was once again named a “Bankruptcy Practice Group of the Year” by Law360.  Weil has received the Bankruptcy Practice Group of the Year honor every year since the inception of the award eight years ago. Weil’s Business Finance and Restructuring Department was named the “Bankruptcy Team of the Year” at the 2018 Chambers Awards and was honored with three restructuring awards by The M&A Advisor in 2018 for its work representing the lenders and sponsors in the chapter 11 restructuring of BCBG Max Azria, its work representing an ad hoc group of term loan lenders in the restructuring of BPS US Holdings and its Debtor affiliates, and its work advising the official committee of unsecured creditors in the chapter 11 restructuring of SunEdison. Some highlights for 2018 include representing:

  • Sears Holdings Corporation in its chapter 11 case
  • Takata in its chapter 11 case
  • Westinghouse Electric in its $9.8 billion chapter 11 case
  • Fieldwood Energy in its chapter 11 case
  • Claire’s Stores in its chapter 11 case
  • Walter Investment Management Corporation its liability management initiative
  • Certain funds sponsored by and affiliates of Bain Capital and Thomas H. Lee Partners as holders of debt and equity in connection with the chapter 11 cases of iHeartMedia and its affiliated debtors
  • Tops Holding II Corporation in its restructuring
  • Southeastern Grocers and 26 of its affiliates in their chapter 11 cases
  • Krayn Wind in connection with the chapter 11 cases of FirstEnergy Solutions
  • National Public Finance Guarantee Corporation in connection with all legal aspects arising from National’s exposure to the Commonwealth of Puerto Rico and its instrumentalities, including representation in the cases commenced under Title III of the Puerto Rico Oversight, Management, and Economic Stability Act by the Commonwealth, Puerto Rico Sales Tax Financing Corporation, Highway and Transportation Authority, and Puerto Rico Electric Power Authority. 

Weil 4 12 2018


Weil’s full-service Litigation Department provides clients with “one-stop” shopping for any type of dispute, encompassing antitrust, securities and commercial litigation, employment litigation, product liability and environmental claims, copyright, trademark, patent and other IP issues, and government and internal investigations. Weil won dozens of victories at all phases of the litigation process, including several trials, and in every practice area in 2018. As a result of our work, in December 2017, Weil was one of just ten firms nationwide that received an Honorable Mention in the General Litigation category in The American Lawyer’s “Litigation Department of the Year” competition for 2018. Weil was also named the sole finalist in the Product Liability “Litigation Department of the Year” category as part of the publication’s annual series. In June 2018, Weil also was named the sole winner in the “Class Action” category in the New York Law Journal’s “Litigation Department of the Year” competition. 

Weil 5 12 2018

Exciting recent engagements include representing:

  • Johnson & Johnson in securing a complete defense jury verdict in the mass tort talc litigation involving allegations of asbestos contamination in New Jersey state court. This lawsuit is one of many cases currently pending in courts around the United States, in which plaintiffs allege that the use of talcum powder caused mesothelioma or ovarian cancer.
  • C&S Wholesale Grocers in securing a complete defense jury verdict in a significant antitrust class action in Minnesota federal court. Brought in as lead trial counsel in 2016, Weil succeeded in erasing several hundred million dollars in potential treble damages, plus attorneys’ fees, and brought nearly a decade of litigation to a close.
  • Sanofi in securing a declination when the DOJ notified the French pharmaceutical giant that it was closing its years-long investigation into potential FCPA violations without bringing an enforcement action, saving the company from a major financial penalty and significant reputational harm. A parallel SEC investigation also was successfully resolved in September 2018.
  • Illumina and Verinata Health in securing a $125+ million jury verdict in a patent infringement dispute with Ariosa Dianostics regarding a revolutionary non-invasive prenatal test. The verdict brought to a close approximately 6 years of litigation.
  • Pandora Media in obtaining a significant appellate victory that upheld in full a favorable determination before the Copyright Royalty Board of sound recording royalty rates for “non-interactive” webcasters for the 2016-2020 license period and will stand to save Pandora hundreds of millions of dollars in royalty payments.
  • Walgreens Boots Alliance in multiple consumer class action lawsuits in California and Arizona arising out of the highly-publicized Theranos blood testing scandal, securing the dismissal of most claims, and then negotiating a settlement from Theranos that indemnified Walgreens from all liability relating to the scandal.
  • Discovery Communications in obtaining Fourth Circuit affirmation of a complete bench trial victory for Discovery Communications and Animal Planet in a significant breach of contract dispute with a former distributor following a multi-week trial in Maryland Federal court.
  • Credit Suisse in winning a unanimous appellate victory before the Ninth Circuit that affirmed the dismissal of all claims in a multi-billion dollar dispute relating to real estate loans.
  • Farmers Insurance in obtaining a rare en banc rehearing of a consolidated appeal before the Eleventh Circuit of almost half a dozen component cases in the MDL entitled In re Auto Body Shop Antitrust Litigation, in which Weil earlier secured the dismissal of all claims at the trial court level. Weil also obtained the dismissal of a related putative RICO class action.
  • Showtime in eliminating a series of putative consumer class actions brought against Showtime in courts around the country relating to the streaming and broadcast of the high-profile boxing match between Floyd Mayweather and UFC star Conor McGregor. Weil earlier obtained the early dismissal of Showtime in a consumer fraud MDL relating to the blockbuster fight between Manny Pacquiao and Floyd Mayweather.
  • Oxford University Press, Cambridge University Press, and SAGE Publications in securing a second consecutive victory before the Eleventh Circuit in a high-profile copyright infringement dispute with Georgia State University involving the contours of the fair use doctrine in the academic setting.
  • Repsol in winning a total victory in a $1 billion environmental litigation in New Jersey state court involving claims of “alter ego” and fraudulent conveyance arising out of the clean-up of the Passaic River, including succeeding on Repsol’s $65 million counterclaim.
  • Life Technologies in securing a major appellate victory in its high-stakes patent dispute with Promega regarding gene-testing technology by extinguishing a $52 million infringement jury verdict Life Technologies suffered in 2012, prior to Weil’s involvement in the case.


The Firm has helped shape U.S. Antitrust policies with our skilled partners – some of which are former government officials – and our unique international network which helps international companies meet the ongoing and unique challenges of globalization. In 2018, the Firm’s Antitrust practice was named “Competition Firm of the Year” by Law360 and “Antitrust Firm of the Year” as part of Legal Media Group’s Annual Life Sciences Awards.

High-profile representations in 2018 include:

  • Scripps Networks in its merger agreement with Discovery Communications, under which Discovery acquired Scripps in a transaction valued at $14.6 billion.
  • Walgreens Boots Alliance in securing antitrust approval for its $5 billion purchase of more than 2000 Rite Aid Stores — one of the largest and most high-profile deals of the past several years, that has had significant impact on the drug store industry.
  • Sanofi in the antitrust aspects of its:
    • $11.6 billion acquisition of Bioverativ, a developer of therapies for the treatment of hemophilia and other rare blood disorders. 
    • $4.8 billion acquisition of Ablynx, a developer of therapeutic protein treatments for human conditions and diseases in the areas of inflammation, hematology, immuno-oncology, oncology, and respiratory diseases.
    • Strategic restructuring with Alnylam of their RNAi therapeutics alliance.
  • Bluegrass Materials and its controlling shareholder, private equity firm Lindsay Goldberg, in the antitrust aspects of its $1.625 billion sale to Martin Marietta Materials